percutaneous: .3% (three in one thousand)
mucosa: .09% (9 in 10,000)
receptive anal intercourse: 1 to 30%
insertive anal intercourse: .1 to 10%
receptive vaginal intercourse: .1 to 10%
insertive vaginal intercourse: .1 to 1%
NEJM 361;18 p1769
RASP Tool
http://www.cjem-online.ca/v5/n1/p46
UK HIV PEP Sexual Exposure Guideline 2011